Fairfield Financial Advisors LTD Has $1.10 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Fairfield Financial Advisors LTD decreased its position in Danaher Co. (NYSE:DHR) by 28.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 3,951 shares of the conglomerate’s stock after selling 1,587 shares during the period. Fairfield Financial Advisors LTD’s holdings in Danaher were worth $1,099,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Good Life Advisors LLC bought a new stake in Danaher in the 3rd quarter valued at approximately $217,000. Oak Thistle LLC bought a new stake in shares of Danaher during the 2nd quarter worth approximately $363,000. Norden Group LLC bought a new stake in shares of Danaher during the 1st quarter worth approximately $4,151,000. Duality Advisers LP bought a new stake in shares of Danaher during the 1st quarter worth approximately $5,573,000. Finally, Diversified Trust Co increased its holdings in shares of Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after acquiring an additional 1,874 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Up 1.7 %

Danaher stock traded up $4.07 during trading hours on Thursday, hitting $246.39. The stock had a trading volume of 1,719,518 shares, compared to its average volume of 2,737,755. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market cap of $182.50 billion, a price-to-earnings ratio of 41.07, a P/E/G ratio of 4.49 and a beta of 0.83. Danaher Co. has a one year low of $188.75 and a one year high of $281.70. The business’s 50 day simple moving average is $267.83 and its 200-day simple moving average is $260.42.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the company earned $2.02 earnings per share. The business’s quarterly revenue was up 3.1% on a year-over-year basis. On average, equities analysts predict that Danaher Co. will post 7.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is 18.31%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Robert W. Baird decreased their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Raymond James decreased their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. UBS Group decreased their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Stifel Nicolaus increased their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Finally, KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.